Literature DB >> 15339078

Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor.

Markella-Pagona Zorzou, Alexandros Stratigos, Eleni Efstathiou, Aristotle Bamias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15339078     DOI： 10.1080/00015550410024634

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  10 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  EGFR inhibitors, MHC expression and immune responses : Can EGFR inhibitors be used as immune response modifiers?

Authors:  Brian P Pollack
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

3.  Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: a potential beneficial effect on psoriasis vulgaris.

Authors:  Ken Okamoto; Hiromichi Maeda; Takeo Shiga; Mai Shiga; Ken Dabanaka; Kazuhiro Hanazaki; Michiya Kobayashi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  A case of psoriasis pustolosa palmaris induced by cetuximab.

Authors:  Elena Marinello; Davide Pastorelli; Mauro Alaibac
Journal:  BMJ Case Rep       Date:  2016-03-18

5.  Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin.

Authors:  Saveria Pastore; Francesca Mascia
Journal:  Expert Rev Dermatol       Date:  2008-10

6.  Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

Authors:  Anna Ferrazzi; Irene Russo; Giulia Pasello; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2015-11-19       Impact factor: 2.447

7.  Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors:  A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal:  Int J Biomed Sci       Date:  2013-09

8.  CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.

Authors:  Sari Suomela; Outi Elomaa; Tiina Skoog; Risto Ala-aho; Leila Jeskanen; Jenita Pärssinen; Leena Latonen; Reidar Grénman; Juha Kere; Veli-Matti Kähäri; Ulpu Saarialho-Kere
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

Review 9.  Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis.

Authors:  Anja K Weidemann; Ania A Crawshaw; Emily Byrne; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-09-26

10.  Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.